Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Eugen Y. H. Wang, Nicklas Pihlström, Per-Uno Malmström & Truls Gårdmark. (2022) Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study. Scandinavian Journal of Urology 56:3, pages 221-226.
Read now
Read now
Eugen Y-H Wang, Ulf Larsson, Truls Gårdmark & Per-Uno Malmström. (2021) Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis. Scandinavian Journal of Urology 55:1, pages 46-52.
Read now
Read now
Per-Uno Malmström, Truls Gårdmark, Amir Sherif, Viveka Ströck, Abolfazl Hosseini-Aliabad, Staffan Jahnson, Firas Aljabery & Fredrik Liedberg. (2019) Incidence, survival and mortality trends of bladder cancer in Sweden 1997–2016. Scandinavian Journal of Urology 53:4, pages 193-199.
Read now
Read now
Andreas Thorstenson, Oskar Hagberg, Börje Ljungberg, Fredrik Liedberg, Georg Jancke, Sten Holmäng, Per-Uno Malmström, Abolfazl Hosseini & Staffan Jahnson. (2016) Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer. Scandinavian Journal of Urology 50:4, pages 292-297.
Read now
Read now
Staffan Jahnson, Abolfazl Hosseini Aliabad, Sten Holmäng, Georg Jancke, Fredrik Liedberg, Börje Ljungberg, Per-Uno Malmström & Johan Rosell. (2016) Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment. Scandinavian Journal of Urology 50:1, pages 14-20.
Read now
Read now
Oliver Patschan, Sten Holmäng, Abolfazl Hosseini, Fredrik Liedberg, Börje Ljungberg, Per-Uno Malmström, Johan Rosell & Staffan Jahnson. (2015) Use of bacillus Calmette–Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort. Scandinavian Journal of Urology 49:2, pages 127-132.
Read now
Read now
Lars Lund, R Erichsen, M Nørgaard, E H Larsen, M Borre & J Jacobsen. (2011) Survival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort study. Clinical Epidemiology 3:sup1, pages 47-51.
Read now
Read now
Staffan Jahnson, Ole Damm, Sverker Hellsten, Sten Holmäng, Fredrik Liedberg, Börje Ljungberg, Per-Uno Malmström, Wiking Månsson, Johan Rosell & Hans Wijkstöm. (2010) Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden. Scandinavian Journal of Urology and Nephrology 44:2, pages 69-75.
Read now
Read now
Andreas Thorstenson, Martin C. Schumacher, N. Peter Wiklund, Martin N. Jonsson, Per Larsson, Hans Wijkström, Erik Onelöv, Gunnar Steineck & Petra J. De Verdier. (2010) Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients. Scandinavian Journal of Urology and Nephrology 44:1, pages 11-19.
Read now
Read now
Staffan Jahnson, Ole Damm, Sverker Hellsten, Sten Holmäng, Fredrik Liedberg, Börje Ljungberg, Per-Uno Malmström, Wiking Månsson, Fredrik Strömberg & Hans Wijkstöm. (2009) A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden. Scandinavian Journal of Urology and Nephrology 43:4, pages 271-276.
Read now
Read now
Articles from other publishers (14)
M. Varma, J.R. Srigley, F. Brimo, E. Compérat, B. Delahunt, M. Koch, A. Lopez-Beltran, V. Reuter, H. Samaratunga, J.H Shanks, T. Tsuzuki, T. van der Kwast, F. Webster & D. Grignon. (2020) Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR). Modern Pathology 33:4, pages 700-712.
Crossref
Crossref
Frank Christoph, Tabea Koch, Simon Blaschke, Frank König, Stefan Lebentrau, Johann Wendler & Martin Schostak. (2019) Instillationstherapie beim nicht muskelinvasiven Harnblasenkarzinom. Uro-News 23:5, pages 40-46.
Crossref
Crossref
Daniel Balan, Orsolya Martha, Calin Bogdan Chibelean, Sabin Tataru, Septimiu Voidezan, Anca Sin, Victor Deliu Matei, Mihai Dorin Vartolomei, Giuseppe Lucarelli, Antonio Cioffi, Francesco Del Giudice, Ettore De Berardinis, Angela Borda, Gian Maria Busetto, Matteo Ferro, Akos Pytel & Daniel Porav-Hodade. (2018) Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors. Medicine 97:16, pages e0522.
Crossref
Crossref
Andreas Thorstenson. (2017) Urothelial Carcinoma of the Bladder in Swedish Geriatric Patients: A Population-based Study. MOJ Gerontology & Geriatrics 1:3.
Crossref
Crossref
Antonio Zizzi, Maria Alessandra Montironi, Roberta Mazzucchelli, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Nicola Paone, Paolo Castellini & Rodolfo Montironi. (2013) Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma. Diagnostic Pathology 8:1.
Crossref
Crossref
Per-Uno Malmström. (2012) Prognostic markers for urothelial cancer: Obstacles and opportunities. Urologic Oncology: Seminars and Original Investigations 30:4, pages 516-517.
Crossref
Crossref
Alon Z. Weizer, Christopher Tallman & Jeffrey S. Montgomery. (2010) Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer. World Journal of Urology 29:1, pages 59-71.
Crossref
Crossref
Eijiro Okajima, Hiroyuki Fujimoto, Yoichi Mizutani, Eiji Kikuchi, Hirofumi Koga, Shiro Hinotsu, Nobuo Shinohara & Tsuneharu Miki. (2010) Cancer death from non‐muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999–2001 registry in Japan. International Journal of Urology 17:11, pages 905-912.
Crossref
Crossref
Vincent J. Low, Duolao Wang & Paul D. Abel. (2010) Survival of patients with bladder cancer from a UK hospital: a 10‐year follow‐up study. BJU International 105:12, pages 1667-1671.
Crossref
Crossref
Miloš Duchek, Robert Johansson, Staffan Jahnson, Oddvar Mestad, Pekka Hellström, Sverker Hellsten & Per-Uno Malmström. (2010) Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study. European Urology 57:1, pages 25-31.
Crossref
Crossref
M. Ulrika Segersten, E. Karolina Edlund, Patrick Micke, Manuel De La Torre, Hans Hamberg, Åsa E.L. Edvinsson, Sandra E.C. Andersson, Per‐Uno Malmström & H. Kenneth Wester. (2009)
A novel strategy based on histological protein profiling
in‐silico
for identifying potential biomarkers in urinary bladder cancer
. BJU International 104:11, pages 1780-1785.
Crossref
Crossref
Eiji Kikuchi, Hiroyuki Fujimoto, Yoichi Mizutani, Eijiro Okajima, Hiroshi Koga, Shiro Hinotsu, Nobuo Shinohara, Mototsugu Oya & Tsuneharu Miki. (2009) Clinical outcome of tumor recurrence for Ta, T1 non‐muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999–2001 report from the Japanese Urological Association. International Journal of Urology 16:3, pages 279-286.
Crossref
Crossref
Per‐Uno Malmström. (2007) WHY HAS THE SURVIVAL OF PATIENTS WITH BLADDER CANCER NOT IMPROVED?. BJU International 101:3, pages 267-269.
Crossref
Crossref
P. Serrano Frago, P. Gil Martínez, M.J. Gil Sanz, M. Allué López, L.A. Rioja Sanz & F. Felipo. (2007) ¿Existen diferencias en las características y en el comportamiento del tumor vesical según edad de presentación? Nuestra experiencia. Actas Urológicas Españolas 31:8, pages 825-830.
Crossref
Crossref